Results 51 to 60 of about 114,570 (194)
Delayed Graft Function and Acute Rejection Following HLA-Incompatible Living Donor Kidney Transplantation [PDF]
Incompatible living donor kidney transplant recipients (ILDKT) have pre-existing donor-specific antibody (DSA) that, despite desensitization, may persist or reappear with resulting consequences, including delayed graft function (DGF) and acute rejection (
Lipkowitz, George, MD +84 more
core +2 more sources
Estimating the probability of positive crossmatch after negative virtual crossmatch [PDF]
This paper estimates the probability of virtual crossmatch failure in kidney exchange matching. In particu-lar, the probability of a positive crossmatch after a negative virtual crossmatch is related to the recipient’s PRA level.
Glorie, K.M. (Kristiaan) +1 more
core +1 more source
Abstract Background Studies suggest that recipients of pathogen reduced (PR) platelets in platelet additive solution (PAS) experience inferior increments when compared to platelets in plasma (PS); however, few real‐world studies have confirmed these observations. In this single‐center study, we evaluated responses to PS and PAS/PR platelets in platelet‐
Olivia McClellan +6 more
wiley +1 more source
Abstract Background and Objectives Immune platelet transfusion refractoriness (PTR) is usually mediated by anti‐HLA class I antibodies; immunisation against CD36 (platelet glycoprotein IV [GPIV]) is relatively rare. Platelet CD36 deficiency shows marked ethnic variability and is seldom reported in admixed Latin American populations.
Rayane Dayse Alves Conserva +11 more
wiley +1 more source
Utility of virtual crossmatch in sensitized patients awaiting heart transplantation.
BACKGROUND: Organ transplant candidates with serum antibodies directed against human leukocyte antigens (HLA) face longer waiting times and higher mortality while awaiting transplantation.
Hurst, Denise +14 more
core +1 more source
Transfusion management of patients with alloanti-Gerbich antibodies: Case report [PDF]
Introduction. Transfusion management of patients who are alloimmunized against high-prevalence erythrocyte antigens is often problematic. Strategy management depends, not only on the specific clinical circumstances of the patient, but also on the ...
Jovanović Radmila +3 more
doaj +1 more source
Abstract Background and Objectives Detection of clinically significant alloantibodies (CSAs), particularly weak or weakly reactive antibodies, remains challenging with conventional agglutination methods and may contribute to delayed haemolytic transfusion reactions (DHTRs).
Rasika Dhawan Setia +4 more
wiley +1 more source
INTRODUCTION: Pretransfusion testing is an essential and important investigation to provide safe and fully compatible packed red blood cell (PRBC) unit to the recipient to prevent the fatal hemolytic transfusion reaction.
I Suresh Kumar +3 more
doaj +1 more source

